CoChat

Redundancy in the World of MAP Kinases: All for One

Open access
Saba-El-Leil, Marc K., Frémin, Christophe, Meloche, Sylvain · 2016 · Frontiers in Cell and Developmental Biology
Cited by 60

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

The protein kinases ERK1 and ERK2 are the effector components of the prototypical ERK1/2 mitogen-activated protein (MAP) kinase pathway. This signaling pathway regulates cell proliferation, differentiation and survival, and is essential for embryonic development and cellular homeostasis. ERK1 and ERK2 homologs share similar biochemical properties but whether they exert specific physiological functions or act redundantly has been a matter of controversy. However, recent studies now provide compelling evidence in support of functionally redundant roles of ERK1 and ERK2 in embryonic development and physiology. In this review, we present a critical assessment of the evidence for the functional specificity or redundancy of MAP kinase isoforms. We focus on the ERK1/ERK2 pathway but also discuss the case of JNK and p38 isoforms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcell.2016.00067

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 102

  1. Aceves-Luquero, 2009, ERK2, but not ERK1, mediates acquired and “de novo” resistance to imatinib mesylate: implication for CML therapy, PLoS ONE, 4, e6124, 10.1371/journal.pone.0006124 · DOI
  2. Adams, 2000, Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development, Mol. Cell, 6, 109, 10.1016/S1097-2765(05)00014-6 · DOI · Paper page
  3. Aebersold, 2004, Extracellular signal-regulated kinase 1c (ERK1c), a novel 42-kilodalton ERK, demonstrates unique modes of regulation, localization, and function, Mol. Cell. Biol., 24, 10000, 10.1128/MCB.24.22.10000-10015.2004 · DOI
  4. Allen, 2000, Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells, J. Exp. Med., 191, 859, 10.1084/jem.191.5.859 · DOI · Paper page
  5. Aoidi, 2016, Functional redundancy of the kinases MEK1 and MEK2: rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect, Sci. Signal., 9, ra9, 10.1126/scisignal.aad5658 · DOI
  6. Beardmore, 2005, Generation and characterization of p38beta (MAPK11) gene-targeted mice, Mol. Cell. Biol., 25, 10454, 10.1128/MCB.25.23.10454-10464.2005 · DOI · Paper page
  7. Bessard, 2008, RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo, Oncogene, 27, 5315, 10.1038/onc.2008.163 · DOI
  8. Bishop, 1999, Acquisition of inhibitor-sensitive protein kinases through protein design, Pharmacol. Ther., 82, 337, 10.1016/S0163-7258(98)00060-6 · DOI
  9. Bonito, 2014, Control of gp130 expression by the mitogen-activated protein kinase ERK2, Oncogene, 33, 2255, 10.1038/onc.2013.159 · DOI
  10. Bost, 2005, The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis, Diabetes, 54, 402, 10.2337/diabetes.54.2.402 · DOI · Paper page
  11. Boulton, 1991, Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies, Cell Regul., 2, 357, 10.1091/mbc.2.5.357 · DOI · Paper page
  12. Boulton, 1991, ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF, Cell, 65, 663, 10.1016/0092-8674(91)90098-J · DOI · Paper page
  13. Boulton, 1990, An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control, Science, 249, 64, 10.1126/science.2164259 · DOI · Paper page
  14. Bourcier, 2006, p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis, Cancer Res., 66, 2700, 10.1158/0008-5472.CAN-05-3129 · DOI · Paper page
  15. Busca, 2015, ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1, BMC Evol. Biol., 15, 179, 10.1186/s12862-015-0450-x · DOI
  16. Chan, 2013, Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis, Blood, 121, 3594, 10.1182/blood-2012-12-476200 · DOI
  17. Chuang, 1994, Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors, FEBS Lett., 346, 229, 10.1016/0014-5793(94)00480-3 · DOI · Paper page
  18. Courcelles, 2013, Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions, Mol. Syst. Biol., 9, 669, 10.1038/msb.2013.25 · DOI · Paper page
  19. Criado, 2014, Alternative p38 MAPKs are essential for collagen-induced arthritis, Arthritis Rheumatol., 66, 1208, 10.1002/art.38327 · DOI
  20. Cuadrado, 2010, Mechanisms and functions of p38 MAPK signalling, Biochem. J., 429, 403, 10.1042/BJ20100323 · DOI · Paper page
  21. Cuenda, 2007, p38 MAP-kinases pathway regulation, function and role in human diseases, Biochim. Biophys. Acta, 1773, 1358, 10.1016/j.bbamcr.2007.03.010 · DOI · Paper page
  22. Davis, 2000, Signal transduction by the JNK group of MAP kinases, Cell, 103, 239, 10.1016/S0092-8674(00)00116-1 · DOI · Paper page
  23. del Barco Barrantes, 2011, Genetic analysis of specific and redundant roles for p38alpha and p38beta MAPKs during mouse development, Proc. Natl. Acad. Sci. U.S.A., 108, 12764, 10.1073/pnas.1015013108 · DOI
  24. Del Reino, 2014, Pro-oncogenic role of alternative p38 mitogen-activated protein kinases p38gamma and p38delta, linking inflammation and cancer in colitis-associated colon cancer, Cancer Res., 74, 6150, 10.1158/0008-5472.CAN-14-0870 · DOI
  25. Di Benedetto, 2007, Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain, J. Comp. Neurol., 500, 542, 10.1002/cne.21186 · DOI
  26. D'Souza, 2008, The Erk2 MAPK regulates CD8 T cell proliferation and survival, J. Immunol., 181, 7617, 10.4049/jimmunol.181.11.7617 · DOI · Paper page
  27. Dudley, 1995, A synthetic inhibitor of the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. U.S.A., 92, 7686, 10.1073/pnas.92.17.7686 · DOI · Paper page
  28. Dumesic, 2009, Erk1/2 MAP kinases are required for epidermal G2/M progression, J. Cell Biol., 185, 409, 10.1083/jcb.200804038 · DOI
  29. English, 1996, Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation, J. Biol. Chem., 271, 24329, 10.1074/jbc.271.40.24329 · DOI · Paper page
  30. Escós, 2016, p38gamma and p38delta mitogen activated protein kinases (MAPKs), new stars in the MAPK galaxy, Front. Cell Dev. Biol., 4, 10.3389/fcell.2016.00031 · DOI · Paper page
  31. Favata, 1998, Identification of a novel inhibitor of mitogen-activated protein kinase kinase, J. Biol. Chem., 273, 18623, 10.1074/jbc.273.29.18623 · DOI · Paper page
  32. Fischer, 2005, The role of erk1 and erk2 in multiple stages of T cell development, Immunity, 23, 431, 10.1016/j.immuni.2005.08.013 · DOI · Paper page
  33. Fremin, 2007, ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes, Hepatology, 45, 1035, 10.1002/hep.21551 · DOI · Paper page
  34. Fremin, 2010, From basic research to clinical development of MEK1/2 inhibitors for cancer therapy, J. Hematol. Oncol., 3, 8, 10.1186/1756-8722-3-8 · DOI · Paper page
  35. Fremin, 2015, Functional redundancy of ERK1 and ERK2 MAP Kinases during development, Cell Rep., 12, 913, 10.1016/j.celrep.2015.07.011 · DOI · Paper page
  36. Furlan, 2012, Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver, J. Hepatol., 57, 1292, 10.1016/j.jhep.2012.07.044 · DOI
  37. Fyffe-Maricich, 2011, The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation, J. Neurosci., 31, 843, 10.1523/JNEUROSCI.3239-10.2011 · DOI · Paper page
  38. Gonzalez, 1991, Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases, J. Biol. Chem., 266, 22159, 10.1016/S0021-9258(18)54548-8 · DOI · Paper page
  39. Gonzalez-Teran, 2013, Eukaryotic elongation factor 2 controls TNF-alpha translation in LPS-induced hepatitis, J. Clin. Invest., 123, 164, 10.1172/JCI65124 · DOI · Paper page
  40. Gonzalez-Teran, 2016, p38gamma and delta promote heart hypertrophy by targeting the mTOR-inhibitory protein DEPTOR for degradation, Nat. Commun., 7, 10477, 10.1038/ncomms10477 · DOI
  41. Grueter, 2006, Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration, J. Neurosci., 26, 3210, 10.1523/JNEUROSCI.0170-06.2006 · DOI · Paper page
  42. Guihard, 2010, The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis, Blood, 115, 3686, 10.1182/blood-2009-09-242487 · DOI
  43. Hanlon, 2001, ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor, J. Biol. Chem., 276, 38449, 10.1074/jbc.M102165200 · DOI
  44. He, 2011, Erk1 positively regulates osteoclast differentiation and bone resorptive activity, PLoS ONE, 6, e24780, 10.1371/journal.pone.0024780 · DOI · Paper page
  45. Heffron, 2009, Brain-specific deletion of extracellular signal-regulated kinase 2 mitogen-activated protein kinase leads to aberrant cortical collagen deposition, Am. J. Pathol., 175, 2586, 10.2353/ajpath.2009.090130 · DOI
  46. Hui, 2007, p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway, Nat. Genet., 39, 741, 10.1038/ng2033 · DOI · Paper page
  47. Hwang, 2009, Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21Cip1, Mol. Cell. Biol., 29, 3379, 10.1128/MCB.01758-08 · DOI
  48. Jaeschke, 2006, JNK2 is a positive regulator of the cJun transcription factor, Mol. Cell, 23, 899, 10.1016/j.molcel.2006.07.028 · DOI · Paper page
  49. Kashiwada, 1996, Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells, Eur. J. Immunol., 26, 1451, 10.1002/eji.1830260708 · DOI
  50. Kultz, 1998, Phylogenetic and functional classification of mitogen- and stress-activated protein kinases, J. Mol. Evol., 46, 571, 10.1007/PL00006338 · DOI · Paper page
  51. Lefloch, 2008, Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels, Mol. Cell. Biol., 28, 511, 10.1128/MCB.00800-07 · DOI · Paper page
  52. Lewis, 1998, Signal transduction through MAP kinase cascades, Adv. Cancer Res., 74, 49, 10.1016/S0065-230X(08)60765-4 · DOI · Paper page
  53. Li, 2009, Efficient inhibition of fibroblast proliferation and collagen expression by ERK2 siRNAs, Biochem. Biophys. Res. Commun., 382, 259, 10.1016/j.bbrc.2009.02.165 · DOI
  54. Li, 1994, Genomic loci of human mitogen-activated protein kinases, Oncogene, 9, 647
  55. Li, 2011, Evolutionary history of the vertebrate mitogen activated protein kinases family, PLoS ONE, 6, e26999, 10.1371/journal.pone.0026999 · DOI
  56. Lips, 2004, MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo, Circulation, 109, 1938, 10.1161/01.CIR.0000127126.73759.23 · DOI · Paper page
  57. Liu, 2004, The MAP kinase pathway is required for entry into mitosis and cell survival, Oncogene, 23, 763, 10.1038/sj.onc.1207188 · DOI
  58. Marchi, 2008, The N-terminal domain of ERK1 accounts for the functional differences with ERK2, PLoS ONE, 3, e3873, 10.1371/journal.pone.0003873 · DOI · Paper page
  59. Marchi, 2010, ERK1 nucleocytoplasmic shuttling rate depends on specific N-terminal aminoacids, Biochem. Biophys. Res. Commun., 398, 166, 10.1016/j.bbrc.2010.06.044 · DOI
  60. Matos, 2005, DNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cells, J. Dermatol. Sci., 39, 113, 10.1016/j.jdermsci.2005.03.011 · DOI
  61. Meloche, 1995, Cell cycle reentry of mammalian fibroblasts is accompanied by the sustained activation of p44mapk and p42mapk isoforms in the G1 phase and their inactivation at the G1/S transition, J. Cell. Physiol., 163, 577, 10.1002/jcp.1041630319 · DOI
  62. Meloche, 2012, Mitogen-activated protein kinases, 1082, 10.1007/978-1-4419-0461-4_193 · DOI
  63. Mudgett, 2000, Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis, Proc. Natl. Acad. Sci. U.S.A., 97, 10454, 10.1073/pnas.180316397 · DOI · Paper page
  64. Nekrasova, 2005, ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis, J. Immunol., 175, 2374, 10.4049/jimmunol.175.4.2374 · DOI · Paper page
  65. Pages, 1993, Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation, Proc. Natl. Acad. Sci. U.S.A., 90, 8319, 10.1073/pnas.90.18.8319 · DOI · Paper page
  66. Papkoff, 1994, p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation, Mol. Cell. Biol., 14, 463, 10.1128/MCB.14.1.463 · DOI
  67. Pearson, 2001, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocr. Rev., 22, 153, 10.1210/er.22.2.153 · DOI · Paper page
  68. Radtke, 2013, ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines, J. Cell Sci., 126, 2381, 10.1242/jcs.115832 · DOI
  69. Remy, 2010, Differential activation of p38MAPK isoforms by MKK6 and MKK3, Cell. Signal., 22, 660, 10.1016/j.cellsig.2009.11.020 · DOI
  70. Ring, 2011, Distinct patterns of activation-dependent changes in conformational mobility between ERK1 and ERK2, Int. J. Mass Spectrom., 302, 101, 10.1016/j.ijms.2010.08.020 · DOI · Paper page
  71. Risco, 2012, New Insights into the p38gamma and p38delta MAPK Pathways, J. Signal Transduct., 2012, 520289, 10.1155/2012/520289 · DOI · Paper page
  72. Risco, 2012, p38gamma and p38delta kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation, Proc. Natl. Acad. Sci. U.S.A., 109, 11200, 10.1073/pnas.1207290109 · DOI · Paper page
  73. Robbins, 1993, Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro, J. Biol. Chem., 268, 5097, 10.1016/S0021-9258(18)53507-9 · DOI · Paper page
  74. Ronai, 2004, JNKing revealed, Mol. Cell, 15, 843, 10.1016/j.molcel.2004.09.011 · DOI
  75. Sabapathy, 2004, Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation, Mol. Cell, 15, 713, 10.1016/j.molcel.2004.08.028 · DOI · Paper page
  76. Sabapathy, 2004, JNK2: a negative regulator of cellular proliferation, Cell Cycle, 3, 1520, 10.4161/cc.3.12.1315 · DOI · Paper page
  77. Sabio, 2005, p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP, EMBO J., 24, 1134, 10.1038/sj.emboj.7600578 · DOI · Paper page
  78. Sabio, 2010, p38gamma regulates interaction of nuclear PSF and RNA with the tumour-suppressor hDlg in response to osmotic shock, J. Cell Sci., 123, 2596, 10.1242/jcs.066514 · DOI
  79. Sarbassov, 1997, Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts, Mol. Endocrinol., 11, 2038, 10.1210/mend.11.13.0036 · doi:10.1210/mend.11.13.0036 · Paper page
  80. Satoh, 2007, Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory, J. Neurosci., 27, 10765, 10.1523/JNEUROSCI.0117-07.2007 · DOI · Paper page
  81. Saulnier, 2012, ERK1 regulates the hematopoietic stem cell niches, PLoS ONE, 7, e30788, 10.1371/journal.pone.0030788 · DOI
  82. Schaeffer, 1998, MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade, Science, 281, 1668, 10.1126/science.281.5383.1668 · DOI · Paper page
  83. Selcher, 2001, Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning, Learn. Mem., 8, 11, 10.1101/lm.37001 · DOI · Paper page
  84. Shaul, 2006, ERK1c regulates Golgi fragmentation during mitosis, J. Cell Biol., 172, 885, 10.1083/jcb.200509063 · DOI · Paper page
  85. Shin, 2013, Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence, Cell. Signal., 25, 2540, 10.1016/j.cellsig.2013.08.014 · DOI
  86. Shin, 2010, ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events, Mol. Cell, 38, 114, 10.1016/j.molcel.2010.02.020 · DOI · Paper page
  87. Staser, 2013, Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk, J. Clin. Invest., 123, 329, 10.1172/JCI66167 · DOI
  88. Tamura, 2000, Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis, Cell, 102, 221, 10.1016/S0092-8674(00)00027-1 · DOI · Paper page
  89. Teis, 2006, p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis, J. Cell Biol., 175, 861, 10.1083/jcb.200607025 · DOI · Paper page
  90. Teis, 2002, Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction, Dev. Cell, 3, 803, 10.1016/S1534-5807(02)00364-7 · DOI · Paper page
  91. Trempolec, 2013, SnapShot: p38 MAPK signaling, Cell, 152, 656, 10.1016/j.cell.2013.01.029 · DOI
  92. Vantaggiato, 2006, ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially, J. Biol., 5, 14, 10.1186/jbiol38 · DOI · Paper page
  93. Voisin, 2010, Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation, Mol. Cell. Biol., 30, 2918, 10.1128/MCB.00131-10 · DOI · Paper page
  94. von Kriegsheim, 2009, Cell fate decisions are specified by the dynamic ERK interactome, Nat. Cell Biol., 11, 1458, 10.1038/ncb1994 · DOI · Paper page
  95. Warr, 2012, Gadd45gamma and Map3k4 interactions regulate mouse testis determination via p38 MAPK-mediated control of Sry expression, Dev. Cell, 23, 1020, 10.1016/j.devcel.2012.09.016 · DOI · Paper page
  96. Wei, 2010, Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation, Cell. Signal., 22, 1783, 10.1016/j.cellsig.2010.07.007 · DOI
  97. Wille, 2007, Epi-allelic Erk1 and Erk2 knockdown series for quantitative analysis of T cell Erk regulation and IL-2 production, Mol. Immunol., 44, 3085, 10.1016/j.molimm.2007.02.008 · DOI
  98. Wollmann, 2005, The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells, Carcinogenesis, 26, 900, 10.1093/carcin/bgi031 · DOI
  99. Wunderlich, 2001, A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment, J. Cell Biol., 152, 765, 10.1083/jcb.152.4.765 · DOI · Paper page
  100. Yoon, 2006, The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions, Growth Factors, 24, 21, 10.1080/02699050500284218 · DOI · Paper page
  101. Yung, 2000, ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK, J. Biol. Chem., 275, 15799, 10.1074/jbc.M910060199 · DOI · Paper page
  102. Zur, 2015, Combined deletion of p38gamma and p38delta reduces skin inflammation and protects from carcinogenesis, Oncotarget, 6, 12920, 10.18632/oncotarget.4320 · DOI

Cited by

Metadata

Authors
Saba-El-Leil, M. K., Frémin, C., & Meloche, S.
Venue
Frontiers in Cell and Developmental Biology
Published
2016-06-27
Volume
4
Pages
67-67
ISSN
2296-634X (ISSN-L)
OpenAlex
W2466439203
Cited by
60
References
14
FWCI
3.91
Type
journal article
Language
en
Open access
gold
Funders
Canadian Institutes of Health Research (MOP-119327)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.